JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1677/jme.0.0220045

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sridaran, R
Right arrow Articles by Papadopoulos, V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sridaran, R
Right arrow Articles by Papadopoulos, V
Journal of Molecular Endocrinology, Vol 22, Issue 1, 45-54
Copyright © 1999 by Society for Endocrinology


Articles

GnRH agonist treatment decreases progesterone synthesis, luteal peripheral benzodiazepine receptor mRNA, ligand binding and steroidogenic acute regulatory protein expression during pregnancy

R Sridaran, GH Philip, H Li, M Culty, Z Liu, DM Stocco, and V Papadopoulos


We have demonstrated that continuous administration of a gonadotropin-releasing hormone agonist (GnRH-Ag) suppresses luteal steroidogenesis in the pregnant rat. We further demonstrated that the peripheral-type benzodiazepine receptor (PBR) and the steroidogenic acute regulatory protein (StAR) play key roles in cholesterol transport leading to steroidogenesis. The purpose of this study was to understand the cellular and molecular mechanisms involved in the suppression of luteal steroidogenesis leading to a fall in serum progesterone levels in GnRH-Ag-treated rats during early pregnancy. Pregnant rats were treated individually starting on day 8 of pregnancy with 5 microgram/day GnRH-Ag using an osmotic minipump. Sham-operated control rats received no treatment. At 0, 4, 8 and 24 h after initiation of the treatment, rats were killed and corpora lutea (CL) were removed for PBR mRNA, protein and radioligand binding analyses, immunoblot 1-D gel analysis of StAR, P450 scc and 3beta-hydroxysteroid dehydrogenase as well as 2-D gel analysis of StAR. The treatment decreased the luteal PBR mRNA expression at all time periods starting at 4 h compared with that in corresponding sham controls. GnRH-Ag also reduced, in the CL, the PBR protein/ligand binding, the StAR protein and P450 scc protein and its activity as early as 8 h after the treatment and they remained low compared with those in corresponding sham controls. The data from 2-D gel studies suggest that the majority of the decrease in StAR protein appears to be in the phosphorylated forms of StAR. Thus, we have demonstrated, for the first time, the presence of PBR and StAR in the pregnant rat CL and that the coordinated suppression of these proteins involved in the mitochondrial cholesterol transport along with P450 scc by GnRH-Ag leads to reduced ovarian steroidogenesis.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Irusta, F. Parborell, and M. Tesone
Inhibition of cytochrome P-450 C17 enzyme by a GnRH agonist in ovarian follicles from gonadotropin-stimulated rats
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1456 - E1464.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Stocco, C. Telleria, and G. Gibori
The Molecular Control of Corpus Luteum Formation, Function, and Regression
Endocr. Rev., February 1, 2007; 28(1): 117 - 149.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Herman and C. Rivier
Activation of a Neural Brain-Testicular Pathway Rapidly Lowers Leydig Cell Levels of the Steroidogenic Acute Regulatory Protein and the Peripheral-Type Benzodiazepine Receptor while Increasing Levels of Neuronal Nitric Oxide Synthase
Endocrinology, January 1, 2006; 147(1): 624 - 633.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Foyouzi, Z. Cai, Y. Sugimoto, and C. Stocco
Changes in the Expression of Steroidogenic and Antioxidant Genes in the Mouse Corpus Luteum During Luteolysis
Biol Reprod, May 1, 2005; 72(5): 1134 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. Parborell, G. Irusta, A. Vitale, O. Gonzalez, A. Pecci, and M. Tesone
Gonadotropin-Releasing Hormone Antagonist Antide Inhibits Apoptosis of Preovulatory Follicle Cells in Rat Ovary
Biol Reprod, March 1, 2005; 72(3): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
V. D. Dixit, H. Yang, V. Udhayakumar, and R. Sridaran
Gonadotropin-Releasing Hormone Alters the T Helper Cytokine Balance in the Pregnant Rat
Biol Reprod, June 1, 2003; 68(6): 2215 - 2221.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Yang, G. K. Bhat, R. Wadley, K. L. Wright, B. M. Chung, J. A. Whittaker, A. M. Dharmarajan, and R. Sridaran
Gonadotropin-Releasing Hormone-Agonist Inhibits Synthesis of Nitric Oxide and Steroidogenesis by Luteal Cells in the Pregnant Rat
Biol Reprod, June 1, 2003; 68(6): 2222 - 2231.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
G. Irusta, F. Parborell, M. Peluffo, P. R. Manna, S. I. Gonzalez-Calvar, R. Calandra, D. M. Stocco, and M. Tesone
Steroidogenic Acute Regulatory Protein in Ovarian Follicles of Gonadotropin-Stimulated Rats Is Regulated by a Gonadotropin-Releasing Hormone Agonist
Biol Reprod, May 1, 2003; 68(5): 1577 - 1583.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. D. Dixit, R. Sridaran, M. A. Edmonsond, D. Taub, and W. E. Thompson
Gonadotropin-Releasing Hormone Attenuates Pregnancy-Associated Thymic Involution and Modulates the Expression of Antiproliferative Gene Product Prohibitin
Endocrinology, April 1, 2003; 144(4): 1496 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Yang, G. K. Bhat, and R. Sridaran
Clinostat Rotation Induces Apoptosis in Luteal Cells of the Pregnant Rat
Biol Reprod, March 1, 2002; 66(3): 770 - 777.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Li, B. Degenhardt, D. Tobin, Z.-x. Yao, K. Tasken, and V. Papadopoulos
Identification, Localization, and Function in Steroidogenesis of PAP7: A Peripheral-Type Benzodiazepine Receptor- and PKA (RI{alpha})-Associated Protein
Mol. Endocrinol., December 1, 2001; 15(12): 2211 - 2228.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. Gavish, I. Bachman, R. Shoukrun, Y. Katz, L. Veenman, G. Weisinger, and A. Weizman
Enigma of the Peripheral Benzodiazepine Receptor
Pharmacol. Rev., December 1, 1999; 51(4): 629 - 650.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society for Endocrinology.